Search research articles
Contact Us
Filters
Showing results (241-250 of 300) with videos related to
Page
of 30
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging
|
May 12, 2023
The use of single-timepoint images to link administered radioiodine activity (MBq) to a prescribed lesion radiation-absorbed dose (cGy): a regression-based prediction interval tool for the management of well-differentiated thyroid cancer patients
Audrey Mauguen, Ravinder K Grewal, Finn Augensen, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
July 22, 2015
PET-based compartmental modeling of (124)I-A33 antibody: quantitative characterization of patient-specific tumor targeting in colorectal cancer
Pat Zanzonico, Jorge A Carrasquillo, Neeta Pandit-Taskar, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 20, 2025
IL13Rα2-Targeting Antibodies for Immuno-PET in Solid Malignancies
Leah Gajecki, Irina V Lebedeva, Yu-Rou Liao, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
September 15, 2023
Toward individualized dosimetry for radiopharmaceutical therapy in day-to-day clinical practice of nuclear oncology: overcoming heterogeneity of radiation-absorbed dose to tumor and critical organs
Lisa Bodei, R Michael Tuttle, Ravinder K Grewal, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
November 25, 2015
Theranostic pretargeted radioimmunotherapy of colorectal cancer xenografts in mice using picomolar affinity ⁸⁶Y- or ¹⁷⁷Lu-DOTA-Bn binding scFv C825/GPA33 IgG bispecific immunoconjugates
Sarah M Cheal, Hong Xu, Hong-Fen Guo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 20, 2005
Progress and promise of FDG-PET imaging for cancer patient management and oncologic drug development
Gary J Kelloff, John M Hoffman, Bruce Johnson, et al.
The Journal of Clinical Investigation
|
September 27, 2016
Sustained ERK inhibition maximizes responses of BrafV600E thyroid cancers to radioiodine
James Nagarajah, Mina Le, Jeffrey A Knauf, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
August 14, 2019
Biodistribution and Dosimetry of Intraventricularly Administered <sup>124</sup>I-Omburtamab in Patients with Metastatic Leptomeningeal Tumors
Neeta Pandit-Taskar, Pat B Zanzonico, Kim Kramer, et al.
Neuro-Oncology
|
February 19, 2025
Phase 1 dose-escalation trial using convection-enhanced delivery (CED) of radio-immunotheranostic 124I-Omburtamab for diffuse intrinsic pontine glioma (DIPG)
Mark M Souweidane, Evan D Bander, Pat Zanzonico, et al.
Molecular Cancer Research : MCR
|
January 6, 2023
Quantitative In Vivo Imaging of the Androgen Receptor Axis Reveals Degree of Prostate Cancer Radiotherapy Response
Claire M Storey, Mohamed Altai, Mesude Bicak, et al.
Page
of 30
Search research articles
Search
Showing results (241-250 of 300) with videos related to
Sort By:
Page
of 30
European Journal of Nuclear Medicine and Molecular Imaging
|
May 12, 2023
The use of single-timepoint images to link administered radioiodine activity (MBq) to a prescribed lesion radiation-absorbed dose (cGy): a regression-based prediction interval tool for the management of well-differentiated thyroid cancer patients
Audrey Mauguen, Ravinder K Grewal, Finn Augensen, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
July 22, 2015
PET-based compartmental modeling of (124)I-A33 antibody: quantitative characterization of patient-specific tumor targeting in colorectal cancer
Pat Zanzonico, Jorge A Carrasquillo, Neeta Pandit-Taskar, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 20, 2025
IL13Rα2-Targeting Antibodies for Immuno-PET in Solid Malignancies
Leah Gajecki, Irina V Lebedeva, Yu-Rou Liao, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
September 15, 2023
Toward individualized dosimetry for radiopharmaceutical therapy in day-to-day clinical practice of nuclear oncology: overcoming heterogeneity of radiation-absorbed dose to tumor and critical organs
Lisa Bodei, R Michael Tuttle, Ravinder K Grewal, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
November 25, 2015
Theranostic pretargeted radioimmunotherapy of colorectal cancer xenografts in mice using picomolar affinity ⁸⁶Y- or ¹⁷⁷Lu-DOTA-Bn binding scFv C825/GPA33 IgG bispecific immunoconjugates
Sarah M Cheal, Hong Xu, Hong-Fen Guo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 20, 2005
Progress and promise of FDG-PET imaging for cancer patient management and oncologic drug development
Gary J Kelloff, John M Hoffman, Bruce Johnson, et al.
The Journal of Clinical Investigation
|
September 27, 2016
Sustained ERK inhibition maximizes responses of BrafV600E thyroid cancers to radioiodine
James Nagarajah, Mina Le, Jeffrey A Knauf, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
August 14, 2019
Biodistribution and Dosimetry of Intraventricularly Administered <sup>124</sup>I-Omburtamab in Patients with Metastatic Leptomeningeal Tumors
Neeta Pandit-Taskar, Pat B Zanzonico, Kim Kramer, et al.
Neuro-Oncology
|
February 19, 2025
Phase 1 dose-escalation trial using convection-enhanced delivery (CED) of radio-immunotheranostic 124I-Omburtamab for diffuse intrinsic pontine glioma (DIPG)
Mark M Souweidane, Evan D Bander, Pat Zanzonico, et al.
Molecular Cancer Research : MCR
|
January 6, 2023
Quantitative In Vivo Imaging of the Androgen Receptor Axis Reveals Degree of Prostate Cancer Radiotherapy Response
Claire M Storey, Mohamed Altai, Mesude Bicak, et al.
Page
of 30